Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07528638
What this trial is testing

Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)

Who this might be right for
Breast CancerSurgery
University of Cincinnati 6
Not applicableLooking for participantsNCT05449691
What this trial is testing

Biological Matrices Versus Synthetic Meshes

Who this might be right for
Breast Cancer
University Hospitals of Derby and Burton NHS Foundation Trust 60
Not applicableStudy completedNCT01664091
What this trial is testing

Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 32
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT06580002
What this trial is testing

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric Cancer+19 more
University of California, Irvine 75
Not applicableStudy completedNCT02521623
What this trial is testing

SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial

Who this might be right for
Breast Neoplasms
Aarhus University Hospital 60
Not applicableUnknownNCT06553859
What this trial is testing

Evaluation of ADM(SC Derm® Recon) in Breast Reconstruction

Who this might be right for
Breast Cancer Female
DOF Inc. 100
Not applicableEnded earlyNCT01243541
What this trial is testing

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Chemotherapeutic Agent ToxicityPainPeripheral Neuropathy+9 more
Northwestern University 33
Early research (Phase 1)Study completedNCT01872923
What this trial is testing

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

Who this might be right for
Cutaneous or Sub-cutaneous Malignancies
PCI Biotech AS 3
Not applicableStudy completedNCT00956384
What this trial is testing

One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure

Who this might be right for
Breast Cancer
University Health Network, Toronto 198
Not applicableStudy completedNCT02061527
What this trial is testing

Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment

Who this might be right for
Breast Cancer
Karolinska University Hospital 135
Not applicableUnknownNCT02557906
What this trial is testing

Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)

Who this might be right for
Breast NeoplasmsBreast Diseases
King's College London 209
Not applicableLooking for participantsNCT06555614
What this trial is testing

Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

Who this might be right for
Breast Cancer FemaleBreast Reconstruction
DOF Inc. 120
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Not applicableStudy completedNCT04593277
What this trial is testing

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8+13 more
Fred Hutchinson Cancer Center 549
Next Page